- Titre
- Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"
- Créateurs - sans rôle
- Juan C. Rosas - German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyMiguel E. Aguado-Barrera - Fdn Publ Galega Med Xen FPGMX, Inst Invest Sanitaria Santiago De Compostela, Santiago De Compostela, SpainDavid Azria - Institut de Recherche en Cancérologie de MontpellierErik Briers - Patient Advocate, Hasselt, BelgiumRebecca Elliott - University of ManchesterMarie-Pierre Farcy-Jacquet - Federat Univ Oncol Radiotherapie Occitanie Mediter, Inst Canc Gard ICG, CHU Caremeau, Nimes, FranceAlexandra Giraldo - Vall Hebron Hosp Univ, Radiat Oncol Dept, Vall Hebron Barcelona Hosp Campus, Barcelona, SpainSara Gutierrez-Enriquez - Vall Hebron Inst Oncol VHIO, Hereditary Canc Genet Grp, Vall Hebron Barcelona Hosp Campus, Barcelona, SpainTiziana Rancati - Ist Nazl Tumori, Data Sci Unit, Milan, ItalyTim Rattay - Vall Hebron Hosp Univ, Radiat Oncol Dept, Vall Hebron Barcelona Hosp Campus, Barcelona, SpainVictoria ReyesBarry Rosenstein - Icahn Sch Med Mt Sinai, New York, NY USADirk De Ruysscher - Maastro Clin, Maastricht, NetherlandsElena Sperk - Heidelberg Univ, Med Fac Mannheim, Mannheim Canc Ctr, Univ Med Mannheim, Mannheim, GermanyHilary Stobart - Independent Canc Patients Voice, London, EnglandChristopher TalbotAna Vega - Fdn Publ Galega Med Xen FPGMX, Inst Invest Sanitaria Santiago De Compostela, Santiago De Compostela, SpainBegona Taboada-Valladares - Fdn Publ Galega Med Xen FPGMX, Inst Invest Sanitaria Santiago De Compostela, Santiago De Compostela, SpainLiv Veldeman - Ghent UniversityTim Ward - NCRI CTRad Consumer, London, EnglandAdam Webb - University of LeicesterCatharine West - Univ Manchester, Manchester, EnglandJenny Chang-Claude - German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyPetra Seibold - German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, GermanyREQUITE Consortiumthe REQUITE Consortium
- Détails de publication
- International journal of cancer, Vol.154(4), pp.759-761
- Éditeur
- Wiley
- Nombre de pages
- 3
- Identifiants
- 99140075909311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Langue
- English
- Type de ressource
- Journal article
Article de revue
Reply to: Comments on "(Pre)treatment risk factors for late fatigue and fatigue trajectories following radiotherapy for breast cancer"
International journal of cancer, Vol.154(4), pp.759-761
15/02/2024
PMID: 37908014
Indicateurs
1 Consultations de la notice